Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Precision neuroimaging aims to deliver individualized assessments of brain health, yet a single structural MRI does not yield a multidimensional, quantitative summary of an individual's current health or future risk. Existing approaches optimize task-specific objectives, yielding representations entangled with cohort- or disease-specific signals rather than capturing biologically grounded patterns...
Human diseases and adverse drug reactions are ultimately recognized through clinical symptoms, yet the molecular determinants of most symptoms remain unknown. To address this key issue, we present PHENOCAUZ, a computational framework that links symptoms to their causative proteins by integrating Mendelian phenotype - gene relationships with molecular features of proteins. Starting from symptom ann...
Predicting whether someone with mild cognitive impairment (MCI) will progress to Alzheimer's disease (AD) is crucial in the early stages of neurodegen...
Resting-state electroencephalography (rs-EEG) offers a cost effective and portable alternative to conventional neuroimaging for dementia screening, ye...
Alzheimer's disease (AD) diagnosis requires integrating neuroimaging with heterogeneous clinical evidence and reasoning under established criteria, ye...
Introduction: The accumulation of senescent cells is a recognized hallmark of biological aging and is associated with the onset of multiple chronic me...
Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in mult...
Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in mult...
Advances in single-cell sequencing and CRISPR technologies have enabled detailed case-control comparisons and experimental perturbations at single-cel...
Early detection of Alzheimer's disease from spontaneous speech has emerged as a promising non-invasive screening approach. However, the influence of a...
Background: Advances in medicine depend on analyzing large and complex data sources, but discovery is partly constrained by the limited time and domai...
Deep learning has become an important tool for Alzheimer's disease (AD) classification from structural MRI. Many existing studies analyze individual 2...
Accurate diagnosis of Alzheimer's disease (AD) requires handling tabular biomarker data, yet such data are often small and incomplete, where deep lear...
Cerebral amyloid angiopathy (CAA) commonly co-occurs with Alzheimer's disease (AD), yet the molecular changes that accompany vascular beta-amyloid dep...
This dissertation investigates privacy-preserving federated learning for Alzheimer's disease classification using three-dimensional MRI data from the ...
Collecting multiple types of data on the same set of subjects is common in modern scientific applications including, genomics, metabolomics, and neuro...
Longitudinal brain MRI is essential for characterizing the progression of neurological diseases such as Alzheimer's disease assessment. However, curre...
Identifying new therapeutic uses for existing drugs is a major challenge in biomedicine, especially for complex neurodegenerative conditions such as A...
We present an EEG-based approach to characterize disease-related spectro-temporal signatures in Alzheimer's disease (AD) and Parkinson's disease (PD)....
Neural Architecture Search (NAS) for object detection is severely bottlenecked by high evaluation cost, as fully training each candidate YOLO architec...